Free US stock screening tools combined with expert analysis to help you identify undervalued companies with strong growth potential. We use sophisticated algorithms and human expertise to surface opportunities that might otherwise go unnoticed.
As of 2026-04-16, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at a current price of $14.13, marking a 1.46% decline in intraday trading. This analysis explores the current market context surrounding the small-cap biotech stock, key near-term technical levels to monitor, and potential future price scenarios based on recent trading patterns. No recent earnings data is available for TNXP at the time of writing, so price action is currently being driven primarily by technical dynamics and broa
Tonix (TNXP) Stock 13F Filings (Underperforming) 2026-04-16 - Intraday Trading
TNXP - Stock Analysis
4927 Comments
719 Likes
1
Juneau
Expert Member
2 hours ago
This feels like a shortcut to nowhere.
👍 193
Reply
2
Kwamae
Legendary User
5 hours ago
I read this and now I feel like I missed it.
👍 94
Reply
3
Jimenez
Power User
1 day ago
The market is consolidating, providing a healthy base for future moves.
👍 65
Reply
4
Ranezmae
Expert Member
1 day ago
Short-term price swings are significant, suggesting that traders remain reactive to news flow.
👍 38
Reply
5
Lyliah
Returning User
2 days ago
Comprehensive US stock investment checklist and decision framework for systematic stock evaluation. Our methodology provides a structured approach to analyzing opportunities and making consistent investment decisions based on proven principles.
👍 124
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.